ATE417106T1 - Chlamydia antigene und deren korrespondierende dna fragmente und verwendungen davon - Google Patents

Chlamydia antigene und deren korrespondierende dna fragmente und verwendungen davon

Info

Publication number: ATE417106T1
Authority: AT; Austria
Prior art keywords: dna fragments; chlamydia; corresponding dna; strain; host
Prior art date: 1999-03-12

Application number

AT00908862T

Other languages

English (en)

Inventor

Andrew Murdin

Raymond Oomen

Joe Wang

Pamela Dunn

Original Assignee

Aventis Pasteur

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-03-12

Filing date

2000-03-09

Publication date

2008-12-15

2000-03-09 Application filed by Aventis Pasteur filed Critical Aventis Pasteur

2008-12-15 Application granted granted Critical

2008-12-15 Publication of ATE417106T1 publication Critical patent/ATE417106T1/de

Links

241000606161 Chlamydia Species 0.000 title abstract 2
239000000427 antigen Substances 0.000 title 1
102000036639 antigens Human genes 0.000 title 1
108091007433 antigens Proteins 0.000 title 1
239000012634 fragment Substances 0.000 title 1
241001647372 Chlamydia pneumoniae Species 0.000 abstract 2
108010052285 Membrane Proteins Proteins 0.000 abstract 2
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 abstract 2
235000018417 cysteine Nutrition 0.000 abstract 2
-1 DNA Chemical class 0.000 abstract 1
102000018697 Membrane Proteins Human genes 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
230000003053 immunization Effects 0.000 abstract 1
238000002649 immunization Methods 0.000 abstract 1
208000015181 infectious disease Diseases 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
238000012986 modification Methods 0.000 abstract 1
230000004048 modification Effects 0.000 abstract 1
102000039446 nucleic acids Human genes 0.000 abstract 1
108020004707 nucleic acids Proteins 0.000 abstract 1
150000007523 nucleic acids Chemical class 0.000 abstract 1
239000002773 nucleotide Substances 0.000 abstract 1
125000003729 nucleotide group Chemical group 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/118—Chlamydiaceae, e.g. Chlamydia trachomatis or Chlamydia psittaci
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Immunology (AREA)
Genetics & Genomics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Microbiology (AREA)
Mycology (AREA)
Communicable Diseases (AREA)
Gastroenterology & Hepatology (AREA)
Oncology (AREA)
Biophysics (AREA)
Engineering & Computer Science (AREA)
Pulmonology (AREA)
Bioinformatics & Cheminformatics (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Saccharide Compounds (AREA)

AT00908862T 1999-03-12 2000-03-09 Chlamydia antigene und deren korrespondierende dna fragmente und verwendungen davon ATE417106T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US12396699P	1999-03-12	1999-03-12

Publications (1)

Publication Number	Publication Date
ATE417106T1 true ATE417106T1 (de)	2008-12-15

Family

ID=22411985

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT00908862T ATE417106T1 (de)	1999-03-12	2000-03-09	Chlamydia antigene und deren korrespondierende dna fragmente und verwendungen davon

Country Status (10)

Country	Link
US (3)	US7183402B2 (de)
EP (2)	EP1163342B1 (de)
JP (1)	JP4832646B2 (de)
AT (1)	ATE417106T1 (de)
AU (1)	AU775695B2 (de)
CA (1)	CA2365196C (de)
DE (1)	DE60041042D1 (de)
MX (1)	MXPA01009256A (de)
NZ (1)	NZ514140A (de)
WO (1)	WO2000055326A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9513371D0 (en) *	1995-06-30	1995-09-06	Biocine Spa	Immunogenic detoxified mutant toxins
EP1169465B1 (de) *	1998-12-04	2006-03-01	University Of Manitoba	Zwei-schritte-verfahren zur impfung gegen chlamydia
US20020061848A1 (en)	2000-07-20	2002-05-23	Ajay Bhatia	Compounds and methods for treatment and diagnosis of chlamydial infection
WO2001036456A2 (en) *	1999-11-15	2001-05-25	Aventis Pasteur Limited	Chlamydia antigens and corresponding dna fragments and uses thereof
EP1240331B1 (de) *	1999-12-22	2010-04-07	Aventis Pasteur Limited	Chlamydia antigene, entsprechende dns fragmente und ihre verwendungen
GB0227346D0 (en) *	2002-11-22	2002-12-31	Chiron Spa	741
EP3156068B1 (de) *	2010-03-29	2021-11-03	CNRS (Centre National de la Recherche Scientifique)	Pharmazeutische zusammensetzungen mit einem polypeptid mit mindestens einem cxxc-motiv und heterologen antigenen und verwendungen davon
KR101397776B1 (ko) *	2010-04-02	2014-05-20	니혼도꾸슈도교 가부시키가이샤	스파크 플러그
CA3004924A1 (en)	2015-11-10	2017-05-18	Ohio State Innovation Foundation	Methods and compositions related to accelerated humoral affinity
US11185555B2 (en)	2016-04-11	2021-11-30	Noah James Harrison	Method to kill pathogenic microbes in a patient

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4879213A (en) *	1986-12-05	1989-11-07	Scripps Clinic And Research Foundation	Synthetic polypeptides and antibodies related to Epstein-Barr virus early antigen-diffuse
US5837268A (en) *	1991-10-16	1998-11-17	University Of Saskatchewan	GnRH-leukotoxin chimeras
US5776746A (en) *	1996-05-01	1998-07-07	Genitope Corporation	Gene amplification methods
US6210876B1 (en) *	1996-06-06	2001-04-03	Abbott Laboratories	Nucleic acid primers and probes for detecting Chlamydia pneumoniae
US20020044949A1 (en) *	1997-04-01	2002-04-18	Harold Kleanthous	76 kda helicobacter polypeptides and corresponding polynucleotide molecules
US6020191A (en) *	1997-04-14	2000-02-01	Genzyme Corporation	Adenoviral vectors capable of facilitating increased persistence of transgene expression
JP4160640B2 (ja) *	1997-06-23	2008-10-01	スヴェンドバークランド	クラミジア・ニューモニエ由来の表面露出タンパク質
JP2002536958A (ja)	1997-11-21	2002-11-05	ジェンセット	Ｃｈｌａｍｙｄｉａｐｎｅｕｍｏｎｉａｅゲノム配列およびポリペプチド、それらのフラグメント、ならびに特に感染症の診断、予防および治療のためのそれらの使用
DE69841894D1 (de) *	1997-11-21	2010-10-21	Merck Serono Biodevelopment Sa	Äusseres Membranpolypeptid von Chlamydia pneumoniae sowie Fragmente davon und deren Verwendung, insbesondere zur Diagnose, Prävention und Behandlung einer Infektion
EP2218731A1 (de)	1997-11-28	2010-08-18	Merck Serono Biodevelopment	Genomsequenz von Chlamydia trachomatis sowie Polypeptide, Fragmente davon und deren Verwendung, insbesondere zur Diagnose, Prävention und Behandlung einer Infektion
US6693087B1 (en)	1998-08-20	2004-02-17	Aventis Pasteur Limited	Nucleic acid molecules encoding POMP91A protein of Chlamydia
WO2000011181A1 (en)	1998-08-20	2000-03-02	Connaught Laboratories Limited	NUCLEIC ACID MOLECULES ENCODING INCLUSION MEMBRANE PROTEIN C OF $i(CHLAMYDIA)
EP1112385A1 (de) *	1998-09-15	2001-07-04	Yale University	Künstliche vektoren mit langen wiederholungssequenzen
MXPA01004291A (es)	1998-10-28	2003-06-09	Aventis Pasteur	Antigenos de chlamydia y fragmentos de acido desoxirribonucleico correspondientes y usos de los mismos.
CA2350775A1 (en)	1998-11-12	2000-05-18	The Regents Of The University Of California	Chlamydia pneumoniae genome sequence
US6822071B1 (en) *	1998-11-12	2004-11-23	The Regents Of The University Of California	Polypeptides from Chlamydia pneumoniae and their use in the diagnosis, prevention and treatment of disease
CA2353107A1 (en)	1998-12-01	2000-06-08	Andrew D. Murdin	Chlamydia antigens and corresponding dna fragments and uses thereof
US20020061848A1 (en)	2000-07-20	2002-05-23	Ajay Bhatia	Compounds and methods for treatment and diagnosis of chlamydial infection
JP2002531129A (ja)	1998-12-08	2002-09-24	コリクサコーポレイション	クラミジア感染の処置および診断のための化合物および方法
US6565856B1 (en)	1998-12-08	2003-05-20	Corixa Corporation	Compounds and methods for treatment and diagnosis of chlamydial infection
GB9828000D0 (en)	1998-12-18	1999-02-10	Chiron Spa	Antigens
US6808713B1 (en)	1998-12-28	2004-10-26	Aventis Pasteur Limited	Chlamydia antigens and corresponding DNA fragments and uses thereof
GB9902555D0 (en)	1999-02-05	1999-03-24	Neutec Pharma Plc	Medicament
DE60036698T2 (de)	1999-05-03	2008-07-24	Sanofi Pasteur Ltd., Toronto	Chlamydia-antigene und entsprechende dna-fragmente und deren verwendungen
NZ517952A (en)	1999-09-20	2004-01-30	Aventis Pasteur	Chlamydia antigens and corresponding DNA fragments and uses thereof
US6632663B1 (en)	1999-09-22	2003-10-14	Aventis Pasteur Limited	DNA immunization against chlamydia infection
WO2001044323A1 (en) *	1999-12-15	2001-06-21	Univation Technologies Llc	Polymerization process
AU2138501A (en)	1999-12-22	2001-07-03	Aventis Pasteur Limited	Chlamydia antigens and corresponding DNA fragments and uses thereof
EP1240331B1 (de)	1999-12-22	2010-04-07	Aventis Pasteur Limited	Chlamydia antigene, entsprechende dns fragmente und ihre verwendungen
US7071245B2 (en) *	2000-04-03	2006-07-04	Mitsubishi Pencil Co., Ltd.	Oil-based ballpoint pen ink composition and oil-based ballpoint pen
US20020132994A1 (en)	2000-04-04	2002-09-19	Murdin Andrew D.	Chlamydia antigens and corresponding DNA fragments and uses thereof
US20020094965A1 (en) *	2000-04-04	2002-07-18	Murdin Andrew D.	Chlamydia antigens and corresponding DNA fragments and uses thereof
US20020082402A1 (en)	2000-04-04	2002-06-27	Murdin Andrew D.	Chlamydia antigens and corresponding DNA fragments and uses thereof
US20020071831A1 (en)	2000-04-04	2002-06-13	Murdin Andrew D.	Chlamydia antigens and corresponding DNA fragments and uses thereof
US20030100706A1 (en)	2000-04-04	2003-05-29	Murdin Andrew D.	Chlamydia antigens and corresponding DNA fragments and uses thereof
WO2001081379A2 (en)	2000-04-21	2001-11-01	Corixa Corporation	Compounds and methods for treatment and diagnosis of chlamydial infection
AU2001258105A1 (en)	2000-05-08	2001-11-20	Aventis Pasteur Limited	Chlamydia antigens and corresponding dna fragments and uses thereof
US20040254130A1 (en)	2000-05-08	2004-12-16	Murdin Andrew D	Chlamydia antigens and corresponding dna fragments and uses thereof
JP2004502415A (ja)	2000-07-03	2004-01-29	カイロン　エセ．ピー．アー．	Ｃｈｌａｍｙｄｉａｐｎｅｕｍｏｎｉａｅに対する免疫化
US6706274B2 (en)	2001-01-18	2004-03-16	Scimed Life Systems, Inc.	Differential delivery of nitric oxide
US7061245B2 (en) *	2004-02-06	2006-06-13	Snap-On Incorporated	Coil-on plug capacitive sensors and passive coil-on plug diagnostic system incorporating same

2000
- 2000-03-09 MX MXPA01009256A patent/MXPA01009256A/es unknown
- 2000-03-09 AT AT00908862T patent/ATE417106T1/de active
- 2000-03-09 EP EP00908862A patent/EP1163342B1/de not_active Expired - Lifetime
- 2000-03-09 DE DE60041042T patent/DE60041042D1/de not_active Expired - Lifetime
- 2000-03-09 NZ NZ514140A patent/NZ514140A/en not_active IP Right Cessation
- 2000-03-09 WO PCT/CA2000/000240 patent/WO2000055326A1/en not_active Ceased
- 2000-03-09 AU AU31383/00A patent/AU775695B2/en not_active Ceased
- 2000-03-09 EP EP08004636A patent/EP2172214A3/de not_active Withdrawn
- 2000-03-09 JP JP2000605744A patent/JP4832646B2/ja not_active Expired - Fee Related
- 2000-03-09 CA CA2365196A patent/CA2365196C/en not_active Expired - Fee Related
2004
- 2004-11-01 US US10/976,917 patent/US7183402B2/en not_active Expired - Fee Related
2005
- 2005-04-18 US US11/107,823 patent/US7285276B2/en not_active Expired - Fee Related
2007
- 2007-09-11 US US11/898,220 patent/US7629327B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US7629327B2 (en)	2009-12-08
JP4832646B2 (ja)	2011-12-07
US20050069942A1 (en)	2005-03-31
JP2002538825A (ja)	2002-11-19
EP1163342B1 (de)	2008-12-10
CA2365196C (en)	2011-11-15
AU775695B2 (en)	2004-08-12
EP2172214A2 (de)	2010-04-07
US20080113933A1 (en)	2008-05-15
US7285276B2 (en)	2007-10-23
WO2000055326A1 (en)	2000-09-21
US7183402B2 (en)	2007-02-27
AU3138300A (en)	2000-10-04
NZ514140A (en)	2001-09-28
EP2172214A3 (de)	2011-03-16
CA2365196A1 (en)	2000-09-21
MXPA01009256A (es)	2003-07-14
US20050186266A1 (en)	2005-08-25
EP1163342A1 (de)	2001-12-19
DE60041042D1 (de)	2009-01-22

Legal Events

Date

Code

Title

Description

2009-07-15

UEP

Publication of translation of european patent specification

Ref document number: 1163342

Country of ref document: EP

Publication	Publication Date	Title
WO2000066739A3 (en)	2001-01-11	Chlamydia antigens and corresponding dna fragments and uses thereof
WO2001046224A3 (en)	2001-12-06	Chlamydia antigens and corresponding dna fragments and uses thereof
WO2001070174A8 (en)	2003-01-16	Vegf-modulated genes and methods employing them
ATE384793T1 (de)	2008-02-15	Chlamydia antigene und entsprechende dna- fragmente und ihre verwendungen
DE60144201D1 (de)	2011-04-21	Lawsonia intracellularis Impfstoff
ATE348892T1 (de)	2007-01-15	Chlamydia antigene, entsprechende dns fragmente und ihre verwendungen
ATE417106T1 (de)	2008-12-15	Chlamydia antigene und deren korrespondierende dna fragmente und verwendungen davon
WO2001046225A3 (en)	2001-12-06	Chlamydia antigens and corresponding dna fragments and uses thereof
WO2001075112A3 (en)	2002-02-28	Chlamydia antigens and corresponding dna fragments and uses thereof
WO2001075111A3 (en)	2002-01-24	Chlamydia antigens and corresponding dna fragments and uses thereof
WO2001075113A3 (en)	2002-08-01	Chlamydia myosin heavy chain homolog as antigen, corresponding dna fragments and uses thereof
WO2001074863A3 (en)	2002-08-01	Chlamydia antigens and corresponding dna fragments and uses thereof
WO2001075114A3 (en)	2002-08-01	Chlamydia transmembrane protein as antigen, corresponding dna fragments and uses thereof
WO2001046226A3 (en)	2002-04-18	Chlamydia antigens and corresponding dna fragments and uses thereof
WO2005026200A3 (en)	2005-06-23	Lawsonia intracellularis subunit vaccine
WO2000006742A3 (en)	2000-04-27	Chlamydia antigens and corresponding dna fragments and uses thereof
MXPA01004353A (es)	2002-07-22	Antigenos de chlamydia y los correspondientes fragmentos de adn y usos de los mismos.
WO2000026239A3 (en)	2000-08-10	$i(chlamydia) antigens and corresponding dna fragments and uses thereof
WO2000011183A3 (en)	2000-06-08	Chlamydia antigens and corresponding dna fragments and uses thereof
DE69925927D1 (de)	2005-07-28	Mutmassliches 98 kd protein des aussenmembrans von chlamydia und dafür kodierende dns sowie deren verwendung
WO2001036455A3 (en)	2001-10-18	Chlamydia antigens and corresponding dna fragments and uses thereof
WO2000006743A3 (en)	2000-05-04	Chlamydia antigens and corresponding dna fragments and uses thereof
WO2000006739A3 (en)	2001-08-16	Chlamydia antigens and corresponding dna fragments and uses thereof
ATE384738T1 (de)	2008-02-15	Chlamydia antigene, entsprechende dna fragmente und ihre verwendungen
WO2001036457A3 (en)	2001-11-01	Chlamydia antigens and corresponding dna fragments and uses thereof